CD4 and neoplasm: TOP2A vaccine treatment significantly increased the proportion of CD4 + Th1 and Th17 cells in breast tumors while decreasing the abundance of Treg cells (Fig. 4l), suggesting that the anti-tumor function of CD4 + T cells was significantly enhanced by TOP2A vaccine treatment.